Clive A. Meanwell's most recent trade in Fractyl Health Inc. was a trade of 596,352 Series F Preferred Stock done . Disclosure was reported to the exchange on Feb. 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Fractyl Health Inc. | Clive A. Meanwell | Director | 06 Feb 2024 | 596,352 | 0 | - | - | Series F Preferred Stock | ||
Fractyl Health Inc. | Clive A. Meanwell | Director | 06 Feb 2024 | 277,890 | 277,890 | - | - | Common Stock | ||
Fractyl Health Inc. | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 45,000 | 45,000 | - | - | Stock Option | |
Invivyd Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 226 | 43,172 | - | - | Earn-out Shares | |
EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 101,010 | 101,010 | - | - | Stock Option (Right to Buy) | |
Invivyd Inc | Clive A. Meanwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 313,500 | 313,500 | - | - | Stock Option (Right to Buy) | |
EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 42,946 | 42,946 | - | - | Earn-out Shares |